Preclinical News and Research

RSS
Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Study explains why south Asians have high susceptibility to developing type 2 diabetes

Study explains why south Asians have high susceptibility to developing type 2 diabetes

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Zalicus announces top-line results from Z160 Phase 2 clinical studies in chronic pain indications

Zalicus announces top-line results from Z160 Phase 2 clinical studies in chronic pain indications

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

BioInvent International receives US patent for drug discovery technology F.I.R.S.T.

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Patrys gets second US patent for anti-cancer product PAT-LM1

Patrys gets second US patent for anti-cancer product PAT-LM1

BioCryst Pharmaceuticals initiates BCX4161 Phase 2a trial in HAE patients

BioCryst Pharmaceuticals initiates BCX4161 Phase 2a trial in HAE patients

New drug combination therapy effectively kills cancer cells

New drug combination therapy effectively kills cancer cells

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

SRI International awarded NIDA contract to study new treatment therapies for substance abuse

Furiex reports financial and operating results for third quarter 2013

Furiex reports financial and operating results for third quarter 2013

Sound Pharmaceuticals completes enrollment for SPI-1005 Phase 2 clinical trial

Sound Pharmaceuticals completes enrollment for SPI-1005 Phase 2 clinical trial

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy

Stem cell therapy after traumatic brain injury promotes lasting cognitive improvement

Stem cell therapy after traumatic brain injury promotes lasting cognitive improvement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.